Skip to main content
Premium Trial:

Request an Annual Quote

Mark Bennett, Ronald Lindsay, Vincent Forlenza, Deborah Neff

Premium

Mark Bennett has become general manager for Asia Pacific of Newcastle upon Tyne, UK-based Nonlinear Dynamics, replacing Alan Koontz, who died last year. Bennett will retain his title and strategic management duties as CEO of Nonlinear’s US subsidiary, Nonlinear USA.

 

Ronald Lindsay has joined the board of directors of AnVil, based in Burlington, Mass. He is currently CSO and vice president of R&D at DiaDexus of San Francisco. Prior to that, he was senior vice president for biotherapeutics at Millennium Pharmaceuticals. Before that, he held positions at Regeneron, the

Sandoz Institute for Medical Research at University College

, London, and the National Institute of Medical Research in Mill Hill, London.

 

Vincent Forlenza has been appointed president of BD Biosciences, based in San Jose, Calif. Most recently, he was the company’s senior vice president for technology, strategy, and development. Forlenza succeeds Deborah Neff, who is leaving BD to pursue other opportunities. He holds a BS in chemical engineering from Lehigh University and an MBA from the Wharton Graduate School at the University of Pennsylvania.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.